{
  "id": 3616,
  "text": "Gynecol Oncol 104, 572-579 (2007).1608.Look, K.Y., Blessing, J.A., Michener, C.M., Rubin, S.& Ramirez, P.T.Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Gynecol Oncol 104, 572-579 (2007).1608.Look, K.Y., Blessing, J.A., Michener, C.M., Rubin, S.& Ramirez, P.T.Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "治疗耐药性非鳞状细胞宫颈癌的化疗药物之一是卡培他滨（Capecitabine）。卡培他滨是一种口服氟尿嘧啶类抗肿瘤药物，被研究用于治疗难治性非鳞状细胞宫颈癌。作为一种化疗方案，卡培他滨可以干扰癌细胞的DNA合成，从而抑制癌细胞的生长和分裂。此外，根据研究数据，这种药物可能对某些患者显示出一定的疗效。因此，对于耐药性宫颈癌患者来说，卡培他滨可能是一个值得考虑的治疗选择。当然，在应用任何化疗药物时，应根据患者的具体情况，综合考虑其疗效和副作用，由专业医疗人员指导使用。",
  "query": "适用于治疗耐药性非鳞状细胞宫颈癌的化疗药物有哪些？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 适用于治疗耐药性非鳞状细胞宫颈癌的化疗药物有哪些？\n\n<reference text>: Gynecol Oncol 104, 572-579 (2007).1608.Look, K.Y., Blessing, J.A., Michener, C.M., Rubin, S.& Ramirez, P.T.Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "治疗耐药性非鳞状细胞宫颈癌的化疗药物之一是卡培他滨（Capecitabine）。卡培他滨是一种口服氟尿嘧啶类抗肿瘤药物，被研究用于治疗难治性非鳞状细胞宫颈癌。作为一种化疗方案，卡培他滨可以干扰癌细胞的DNA合成，从而抑制癌细胞的生长和分裂。此外，根据研究数据，这种药物可能对某些患者显示出一定的疗效。因此，对于耐药性宫颈癌患者来说，卡培他滨可能是一个值得考虑的治疗选择。当然，在应用任何化疗药物时，应根据患者的具体情况，综合考虑其疗效和副作用，由专业医疗人员指导使用。"
}